Research poster: The current impact of ICER assessments on payer decision making

Assessments from the Institute for Clinical and Economic Review (ICER) are used in price negotiations and to implement prior authorizations, according to a recent survey of payers in Xcenda's Managed Care Network (MCN). 

According to a recent survey conducted by Xcenda and presented at the annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in May 2022, payers see value in the cost-effectiveness analyses and policy reports conducted by ICER. 

View the poster presented at ISPOR 2022 below.